FIELD: biotechnology.
SUBSTANCE: invention relates to antibodies imitating morphine-specific antigenic properties and capable of binding to opioid receptors.
EFFECT: obtained monoclonal antibody AI-K11B binds to opiate receptors and induces, during immunization, antibodies specifically recognizing derivatives of morphine.
3 cl, 6 tbl, 3 ex, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
MONOCLONAL ANTI-IDIOTYPIC ANTIBODY AI-G1, HAVING ANTIGENIC PROPERTIES OF MORPHINE | 2019 |
|
RU2717989C1 |
MONOCLONAL ANTIBODY 3K11 TO MORPHINE DERIVATIVES | 2018 |
|
RU2702002C1 |
MONOCLONAL ANTIBODY 6G1 TO MORPHINE DERIVATIVES | 2018 |
|
RU2703494C1 |
MONOCLONAL ANTIBODY SS3-4 TO CONFORMATION HUMAN EPITOPE C3, STRAIN OF HYBRID MOUSE DNA RKKK(P)764D - PRODUCER OF MONOCLONAL ANTIBODY SS3-4 | 2015 |
|
RU2584582C1 |
IMMUNOGEN FOR TREATING AND PREVENTING OPIATE ADDICTION | 2013 |
|
RU2548802C1 |
MONOCLONAL ANTIBODY TO THE C- TERMINAL FRAGMENT OF ANTI -MULLER HORMONE | 2021 |
|
RU2770003C1 |
MONOCLONAL ANTIBODY AGAINST THE C-TERMINAL FRAGMENT OF ANTI-MULLERIAN HORMONE | 2021 |
|
RU2764795C1 |
MONOCLONAL ANTIBODIES TO C-END FRAGMENT OF ANTI-MULLER HORMONE | 2018 |
|
RU2765689C2 |
MONOCLONAL ANTIBODY, BINDING WITH EBOLA VIRUS GLYCOPROTEIN, DNA FRAGMENTS CODING THIS ANTIBODY, AND ANTIGEN-BINDING FRAGMENT | 2015 |
|
RU2630304C2 |
MONOCLONAL ANTIBODY, BINDING WITH EBOLA VIRUS GLYCOPROTEIN, DNA FRAGMENTS CODING THIS ANTIBODY, AND ANTIGEN-BINDING FRAGMENT | 2015 |
|
RU2639533C2 |
Authors
Dates
2021-03-24—Published
2020-03-03—Filed